Stevens-Johnson Syndrome Completed Phase 1 / 2 Trials for Riboflavin (DB00140)

Also known as: SJS / Stevens-­Johnson syndrome / Stevens‑Johnson syndrome / Stevens-Johnson syndrome (SJS) / Stevens Johnson syndrome / Stevens Johnson reaction / Erythema exsudativum multiforme / Erythema multiforme major / Bullous erythema multiforme / Syndrome Stevens-Johnson / (Erythema multiforme) or (necrolysis: [antibiotic] or [toxic]) or (Stevens-Johnson syndrome) / Stevens Jonhson syndrome / Erythema exudativum multiforme / Erythema multiforme exudativum / Stevens-Johnson syndrome (disorder)

IndicationStatusPhase
DBCOND0001814 (Stevens-Johnson Syndrome)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01582880Use of Cross-linked Donor Corneas as Carriers for the Boston KeratoprosthesisTreatment